Skip to main content

Seasonal Allergic Conjunctivitis News

Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use

BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...

FDA Approves Tris Pharma's New Drug Application for Karbinal ER

MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...

Ask a question

To post your own question to our community, sign in or create an account.